Viewpoint
Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential

https://doi.org/10.1016/0165-6147(93)90128-7Get rights and content

Abstract

There has been tremendous interest in 5-HT3 receptor antagonists since their discovery and the subsequent identification of 5-HT3 receptors in the CNS. Based on the results of early behavioural tests with these compounds, there has been substantial interest in their potential use for the treatment of various CNS disorders. In this review, Andrew Greenshaw attempts to clarify the status of the therapeutic potential of these drugs, discussing inconsistencies in preclinical findings and identifying areas in need of clarification through future research. 5-HT3 receptor antagonists are claimed to be potentially useful in the treatment of nausea, inflammatory pain (migraine and irritable bowel syndrome), anxiety, depression, schizophrenia, dementia and drug abuse!.

References (54)

  • J.A. Peters et al.

    Trends pharmacol. Sci.

    (1992)
  • I. Angel et al.

    Eur. J. Pharmacol.

    (1993)
  • S.R. Glaum et al.

    Brain Res.

    (1990)
  • M. Papp

    Eur. J. Pharmacol.

    (1988)
  • P.E. Mele et al.

    Eur. J. Pharmacol.

    (1992)
  • B. Gao et al.

    Neuropharmacology

    (1992)
  • D.J. Bill et al.

    Eur. J. Pharmacol.

    (1992)
  • R.M. Hagan

    Eur. J. Pharmacol.

    (1987)
  • A. Imperato et al.

    Neurosci. Lett.

    (1989)
  • Q. Pei et al.

    Eur. J. Pharmacol.

    (1993)
  • P.C. Moser

    Eur. J. Pharmacol.

    (1990)
  • L.J. Herberg et al.

    Neurosci. Lett.

    (1992)
  • J.D. Lane

    Drug Alcohol Depend.

    (1992)
  • S.L. McBain

    Schizo. Ref.

    (1992)
  • E.J. Bilsky et al.

    Pharmacol. Biochem. Behav.

    (1991)
  • P.C. Moser

    Eur. J. Pharmacol.

    (1992)
  • E.M. Sellers et al.

    Trends Pharmacol. Sci.

    (1992)
  • P. Martin et al.

    Eur. J. Pharmacol.

    (1992)
  • J. Adrien

    Neuropharmacology

    (1992)
  • A.M. Domeney

    Pharmacol. Biochem. Behav.

    (1991)
  • K. Bunce et al.

    Trends Pnarmacol. Sci.

    (1991)
  • E. Zifa et al.

    Pharmacol. Rev.

    (1992)
  • A.A. Alhaider et al.

    J. Neurosci.

    (1992)
  • J.R. Fozard
  • S.T. Mellor et al.

    Brain Res.

    (1992)
  • E. Acquas et al.

    Psychopharmacology

    (1990)
  • F. Jenck et al.

    Psychopharmacology

    (1989)
  • Cited by (0)

    View full text